Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 22,500 shares at $11.89 ($275K) on 2013-02-22, disclosed to the SEC on 2013-02-26.
Scheduled sale ($275k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.89 | 99 | $1K | 0.4% |
| 2 | $12.05 | 7,401 | $89K | 32.4% |
| 3 | $12.04 | 99 | $1K | 0.4% |
| 4 | $12.28 | 7,401 | $91K | 33.0% |
| 5 | $12.22 | 99 | $1K | 0.4% |
| 6 | $12.35 | 5,000 |
| $62K |
| 22.4% |
| 7 | $12.40 | 2,401 | $30K | 10.8% |
| Total | $12.23 avg | 22,500 | $275K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |